UPDATE 1-Cell Therapeutics starts late-stage Xyotax study
September 26th, 2007
 U.S.-Italian drug firm Cell Therapeutics Inc has begun a late-stage clinical trial involving its Xyotax drug for women with an advanced form of lung cancer, the company said on Monday.